Cabot earnings were $311.0M for the trailing 12 months ending Dec 31, 2025, with -24.2% growth year over year. The latest CBT earnings report on Dec 31, 2025 announced Q4 2025 earnings of $73.0M, up 69.8% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, CBT reported annual earnings of $331.0M, with -12.9% growth.
CBT past earnings growth
How has CBT's earnings growth performed historically?
On CBT's earnings call on Invalid Date, Cabot (NYSE: CBT) reported Q4 2025 earnings per share (EPS) of $1.38, up 18.34% year over year. Total CBT earnings for the quarter were $73.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $1.69.
As of the last Cabot earnings report, Cabot is currently profitable. Cabot's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $311.00 million, a 26.48% decrease year over year.
What was CBT's earnings growth in the past year?
As of Cabot's earnings date in Invalid Date, Cabot's earnings has grown -24.21% year over year. This is 28.42 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 4.21%. CBT earnings in the past year totalled $311.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.